Personalized prostate cancer care: From screening to treatment
- Author:
Carly CONRAN
1
Author Information
- Publication Type:Journal Article
- Keywords: genetic risk score; prostate cancer; pyramid model; single nucleotide polymorphisms
- From: Asian Journal of Andrology 2016;18(4):505-508
- CountryChina
- Language:Chinese
- Abstract: Unprecedented progress has been made in genomic personalized medicine in the last several years, allowing for more individualized healthcare assessments and recommendations than ever before. However, most of this progress in prostate cancer (PCa) care has focused on developing and selecting therapies for late-stage disease. To address this issue of limited focus, we propose a model for incorporating genomic-based personalized medicine into all levels of PCa care, from prevention and screening to diagnosis, and ultimately to the treatment of both early-stage and late-stage cancers. We have termed this strategy the "Pyramid Model" of personalized cancer care. In this perspective paper, our objective is to demonstrate the potential application of the Pyramid Model to PCa care. This proactive and comprehensive personalized cancer care approach has the potential to achieve three important medical goals: reducing mortality, improving quality of life and decreasing both individual and societal healthcare costs.
